Mounjaro Injection for Diabetes: What It Does and Who It Suits (October 2026)

01 · The core answer

What does Mounjaro do for diabetes?

Mounjaro improves blood sugar control and supports weight loss in people with diabetes. Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss.¹ It is given as a once-weekly injection under the skin, using a pre-filled pen.

The mechanism is what makes it different. Tirzepatide activates two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ For a deeper walk-through, see our guide on how Mounjaro helps diabetes.

02 · Your decision

Can Mounjaro be prescribed for diabetics?

Yes. Type 2 diabetes is one of the licensed uses, so people with the condition can be prescribed it where a prescriber judges it suitable. NICE has published separate guidance on tirzepatide for diabetes and for obesity, and your own situation decides which applies.⁸⁴

Two practical questions matter most. First, are you already under a diabetes team? If so, they are the right first call, because treatment and monitoring are coordinated differently when you have diabetes.¹ Second, are you also looking at weight management?

The medicines you already take matter too. If you use insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. That is a conversation for your prescriber and diabetes team, not something to change yourself. Never stop or alter existing diabetes medicines without their advice.

03 · What to do next

Where to go from here

If you want to start private treatment, a free online consultation is reviewed by a GPhC-registered prescriber, so be ready to share your diabetes diagnosis and current medicines. You can see the Mounjaro pen, prices and consultation on our product page. If you are curious about the wider picture, our weight loss clinic explains how treatment is supported.

04 · How it works

How the injection works in the body

Mounjaro works on two hormone pathways at once. Tirzepatide is the first treatment of its kind to activate both GIP and GLP-1 receptors. This dual action is what distinguishes it from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹

For someone with diabetes, the relevant effects are better response to insulin and slower stomach emptying. Slower emptying also means most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹

Because it is a weekly medicine, the effect is steady rather than tied to mealtimes. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

If you are comparing medicines used for people with diabetes who also want to lose weight, our overview of weight loss injection medication for diabetes sets the options side by side, and the page on the diabetes weight loss injection covers the same ground from the weight angle.

05 · Dosing and injecting

Dosing, titration and how to inject

Everyone starts Mounjaro on 2.5mg once a week. This starting dose is about letting your body adjust, not about weight loss itself. After at least 4 weeks the dose increases to 5mg, and can then step up by 2.5mg at a minimum of 4-week intervals (7.5mg, 10mg, 12.5mg) up to a maximum of 15mg weekly, depending on how you respond and tolerate it.¹

Many people settle at a maintenance dose of 5mg, 10mg or 15mg. Higher is not automatically better, and your prescriber will guide the right pace.¹ Where blood sugar is the main goal, your diabetes team may have views on the target dose, so share any plan you have been given.

Mounjaro is injected under the skin (subcutaneously) once a week, on the same day each week, at any time of day, with or without food. Rotate the site with each dose.¹³ Licensed injection sites are the stomach area (at least 5cm from the belly button), the front of the thigh, or the back of the upper arm if someone else gives the injection.¹³ Each KwikPen contains four weekly doses.

There is no best time of day. Mounjaro works the same morning or evening, with or without food, and what matters is the same day each week.¹ If you want a refresher on handling the pen, read our Mounjaro injection technique guide.

If something seems to go wrong during an injection, our page on a failed Mounjaro injection explains what to do.

06 · Missed doses and storage

Missed doses, storage and travel

If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time, then carry on with your usual day. If more than 4 days have passed, skip the missed dose entirely and take the next one on your normal day. Never take two doses within 3 days of each other.¹ You can change your injection day if needed, as long as at least 3 days (72 hours) have passed since your last dose.¹

Keep pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, useful for short trips, after which it should be discarded. Keep the pen cap on to protect it from light.¹³

You can fly with Mounjaro. Carry pens in hand luggage, because hold luggage can fall below freezing, ideally in a cool bag with the prescription label or a copy of your prescription. Check destination rules for travelling with prescription injectables before you fly.¹³ If an unopened pen has been out of the fridge, check with the pharmacy before using it rather than relying on a remembered day limit, because figures circulating online often come from other countries' labels.

People with diabetes often carry other supplies, so plan the cool bag, sharps and medicine list together before a trip.

07 · Side effects

Side effects of the Mounjaro diabetic shot

The commonest early effects are mild and tend to settle. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.¹ Many people choose a weekend morning so that early side effects fall on days off.

Common and very common effects include feeling sick, diarrhoea, being sick, stomach pain, constipation, feeling tired and reduced appetite, and low blood sugar when used with a sulfonylurea or insulin. Hair loss, injection-site reactions, indigestion and dizziness are also common. Tell your prescriber about any new or lasting symptom.¹³

Because you have diabetes, one point deserves emphasis. If you also use insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. Tell your prescriber at the start so a plan is in place.

If you notice a new or lasting symptom, tell your prescriber. You can also report any suspected side effect through the MHRA Yellow Card scheme.¹⁹

08 · Living with treatment

Food, what to avoid, kidneys and the long term

Mounjaro is used alongside a reduced-calorie diet and increased physical activity.¹ In practice, because the medicine slows stomach emptying and makes most people feel fuller sooner, many find smaller, regular meals easier than large ones. If you have diabetes, keep following the eating advice your diabetes team has given you.

Mounjaro is not known to damage kidneys or liver directly. The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys, so keep fluids up and contact your clinical team if you cannot keep fluids down. Tell your prescriber if you have existing kidney problems or take several medicines. Report anything unexpected through the Yellow Card scheme.

Treatment is reviewed rather than fixed. For weight management, the guidance is that if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.¹ For diabetes control, your diabetes team judges ongoing benefit using your blood sugar results.

Weight loss is gradual by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month.¹

09 · Trial results

What the weight-loss trials showed

The best-known trial of tirzepatide for weight is SURMOUNT-1. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages, and individual results vary. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² That trial was in adults with obesity, so treat it as context for weight rather than a forecast for blood sugar results.

For blood sugar, ask your diabetes team what to expect for your own HbA1c, because they know your starting point.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · NHS or private

NHS or private supply

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you have diabetes, your NHS diabetes team is the first place to ask. A private prescription does not replace that relationship, so keep your team informed either way. If you choose private treatment, the pharmacy is on the GPhC register (9012878) and the pens are genuine KwikPens supplied direct from Eli Lilly through LillyDirect. Delivery is free next-day and tracked in temperature-controlled packaging, and same-day dispatch applies when ordered by 3pm.

Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. This page is information, not a substitute for medical advice.